In every issue of HEP, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Former NFL star turned activist Rolf Benirschke kicks hepatitis C.
Rolf Benirschke became a hepatitis C virus (HCV) treatment advocate after he tested HCV positive while applying for life insurance in 1998.
Herbal and dietary supplements are now a major risk factor for chemical-induced liver damage across the United States.
#FairDrugPricesNow campaign calls for more transparency among drug companies.
New app allows people living with HCV to take part in a research study aimed at tracking antiviral medication effects.
First hospital in the United States performs a liver transplant using a new high-tech machine are calling the “liver in a box.”
German study shows high hepatitis C virus cure rates after eight weeks of Harvoni (ledipasvir/sofosbuvir) treatment.
An experimental hepatitis C virus (HCV) treatment regimen given for just six or eight weeks has shown promise in a mid-stage trial.
Treating all those with hepatitis C virus (HCV) who are on Medicaid would save money and improve the health and longevity of the population.
Hepatitis C virus (HCV) cure rates among those who have received a liver transplant are very good.